
Sign up to save your podcasts
Or


Kevin Lee, CEO of Bicycle Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Bicycle Therapeutics is working on developing a new class of medicines, called Bicycles, for diseases that are underserved by existing therapeutics.
By John Simboli5
77 ratings
Kevin Lee, CEO of Bicycle Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Bicycle Therapeutics is working on developing a new class of medicines, called Bicycles, for diseases that are underserved by existing therapeutics.

3,067 Listeners

1,943 Listeners

1,093 Listeners

2,364 Listeners

949 Listeners

795 Listeners

123 Listeners

321 Listeners

6,071 Listeners

94 Listeners

9,997 Listeners

519 Listeners

146 Listeners

249 Listeners

180 Listeners